ATR-IN-1
ATR-IN-1 is a selective ATR inhibitor with an IC50 of 0.5 nM. ATR-IN-1 shows no hERG inhibitory effect. ATR-IN-1 inhibits the growth of ATM-deficient melanoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1639974-69-8
- Formel: C18H19N7O
- Molecular Weight:349.40
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
ATR 0.5 nM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HT-144 | GI50 |
0.35 μM
|
Inhibition of growth of ATM-null human HT144 melanoma cells after 72 hrs continuous exposure measured by CellTiter-Glo assay.
Inhibition of growth of ATM-null human HT144 melanoma cells after 72 hrs continuous exposure measured by CellTiter-Glo assay.
|
25589928 |
In Vitro
ATR-IN-1 (Compound 13) inhibits ATR with an IC50 of 0.0005 µM and shows selectivity over ATM (IC50 15 µM) and DNAPK (IC50 >25 µM)[1].
ATR-IN-1 (1 h) does not inhibit mTOR signaling in TSC1−/− MEF cells (IC50 >13 µM)[1].
ATR-IN-1 has a hERG IC50 >30 µM by automated whole-cell electrophysiology[1].
ATR-IN-1 does not inhibit CYP3A4, 2D6, 2C9, or 1A2 (IC50 >24 µM)[1].
ATR-IN-1 (72 h) inhibits the growth of ATM-null HT144 melanoma cells with a GI50 of 0.35 µM after 72 h continuous exposure[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 1639974-69-8
-
Molecular Weight 349.40
-
Formel C18H19N7O
-
SMILES
C[C@H]1N(C2=C3C(=CC(=N2)C4=C5C(NC=C5)=CN=N4)N(C)C=N3)CCOC1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)